ArticleFrontiers in oncology2025

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients.

Dong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.